FCCC LOGO Faculty Publications
David KA , Smith MR , Lossos IS , Roubal E , Winter JN , Rosen ST , Gordon LI , Evens AM
A Phase II Trial of Combination Bortezomib (Velcade (R)) and Rituximab for Untreated "High Tumor Burden" Indolent Non-Hodgkin Lymphoma (NHL)
. 2008 :699-699
PMID: ISI:000262104702337   
Back to previous list
Abstract
Notes
David, Kevin A. Smith, Mitchell R. Lossos, Izidore S. Roubal, Eren Winter, Jane N. Rosen, Steve T. Gordon, Leo I. Evens, Andrew M. 0 389OP